AAAAAA

   
Results: 1-12 |
Results: 12
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
Authors: Steiner, G Hamsten, A Hosking, J Stewart, D McLaughlin, P Gladstone, P Sole, M Syvanne, M Hamsten, A Camelon, K Schloegl, G Genest, J Reeves, F Savard, R Letarte, A Bellavance, N Touchette, J Latour, Y Marchand, P Rondeau, C Rivard-Gervais, N Belanger, A Hamel, D Dumas, R Sandri, M Morin, N Caponi, E Barbeau, C Gauthier, S Ooi, TC Davies, RF Braaten, JT Baker, A Favreau, C Collar, C Zinman, B Gladstone, P Aldridge, H Donat, DJ Tsui, E Barnie, A DiMonte, L MacLean, S Bond, M Camelon, K Martin, C Zawacki, R Dziuran, K Gouveia, MR Taskinen, MR Nieminen, M Nikkila, K Virtanen, K Makimattila, S Malmstrom, R Kohtamaki, H Jamsen, P Salo, A Puupponen, M Kesaniemi, A Ikaheimo, M Ukkola, O Salmela, P Savolainen, M Huikuri, H Airaksinen, J Koistinen, J Mannermaa, L Ukkola, L Ketonen, K Silaste, ML Salovaara, A Efendic, S Svane, B Hellekant, C Bavenholm, P Karlen, A Hadell, K Hamsten, A Franson, K Mohlkert, D Nordlander, R Ehrenstig, L Tan, MH Title, LM Johnstone, D Winch, S Higgins-Bowser, I Shlossberg, A Murdock, H Elliott, T Fung, A Jalbert, A Leung, S Turnbull, S Norman, E Valensi, P Farez, C Tavolaro, O Sachs, RN Sedjari, F Laakso, M Kettunen, R Eranen, J Lehto, S Raisanen, R Jantunen, A Valve, R Toivanen, A Frohlich, J Vannetta, H Bowden, F Seccombe, DW Ehnholm, C Gref, CG Ikonen, M Sundvall, J Seccombe, DW McGuinness, C Ho, A Hamilton, J Pritchard, H McLaughlin, P Gladstone, P Allard, N Bond, M Bui, S Van der Wal, H Hosking, J Davis, CE Tyroler, HA Stewart, D Curtis, RC Miles, M Khaltaev, N Sole, M Kirkeeide, R Frick, H Hata, Y Rifkind, B Zimmet, P Gent, M Schonfeld, G de Bono, D Reeves, F Carter, A Ansquer, JC Fraitag, B Guivarc'h, PH Irvine, A Jacovella, J Munoz, A Rode, H Yacine, A Asmar-Kristiansen, D Bonnefous, F Belanger, F Bond, M Brown, M DeLorme, L Galos, C Jenkins, R Lanoue, C Moussalli, R Murtomaki, E Zandomenighi, F
Citation: G. Steiner et al., Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study, LANCET, 357(9260), 2001, pp. 905-910
In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene
Authors: Elias, N Patterson, BW Schonfeld, G
Citation: N. Elias et al., In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene, ART THROM V, 20(5), 2000, pp. 1309-1315
A targeted apolipoprotein B-38.9-producing mutation causes fatty livers inmice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides
Authors: Chen, ZJ Fitzgerald, RL Averna, MR Schonfeld, G
Citation: Zj. Chen et al., A targeted apolipoprotein B-38.9-producing mutation causes fatty livers inmice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides, J BIOL CHEM, 275(42), 2000, pp. 32807-32815
Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22
Authors: Yuan, B Neuman, R Duan, SH Weber, JL Kwok, PY Saccone, NL Wu, JS Liu, KY Schonfeld, G
Citation: B. Yuan et al., Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22, AM J HU GEN, 66(5), 2000, pp. 1699-1704
Measurements of rate of transcription in isolated nuclei by nuclear "run-off" assay
Authors: Srivastava, RAK Schonfeld, G
Citation: Rak. Srivastava et G. Schonfeld, Measurements of rate of transcription in isolated nuclei by nuclear "run-off" assay, NUCLEIC ACID PROTOCOLS HANDBOOK, 2000, pp. 207-212
Effects of alcohol and cholesterol feeding on lipoprotein metabolism and cholesterol absorption in rabbits
Authors: Latour, MA Patterson, BM Kitchens, RT Ostlund, RE Hopkins, D Schonfeld, G
Citation: Ma. Latour et al., Effects of alcohol and cholesterol feeding on lipoprotein metabolism and cholesterol absorption in rabbits, ART THROM V, 19(3), 1999, pp. 598-604
Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia
Authors: Elias, N Patterson, BW Schonfeld, G
Citation: N. Elias et al., Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia, ART THROM V, 19(11), 1999, pp. 2714-2721
Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemicknock-out mice expressing truncated apoB, B81. Low production and enhancedclearance of apoB cause low levels of apoB
Authors: Srivastava, RAK Toth, L Srivastava, N Hinsdale, ME Maeda, N Cefalu, AB Averna, M Schonfeld, G
Citation: Rak. Srivastava et al., Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemicknock-out mice expressing truncated apoB, B81. Low production and enhancedclearance of apoB cause low levels of apoB, MOL C BIOCH, 202(1-2), 1999, pp. 37-46
Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene
Authors: Srivastava, RAK Srivastava, N Averna, M Cefalu, AB Schonfeld, G
Citation: Rak. Srivastava et al., Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene, J LIPID RES, 40(5), 1999, pp. 901-912
Known mutations of apoB account for only a small minority of hypobetalipoproteinemia
Authors: Wu, JS Kim, J Li, Q Kwok, PY Cole, TG Cefalu, B Averna, M Schonfeld, G
Citation: Js. Wu et al., Known mutations of apoB account for only a small minority of hypobetalipoproteinemia, J LIPID RES, 40(5), 1999, pp. 955-959
Truncated apo B-70.5-containing lipoproteins bind to megalin but not the LDL receptor
Authors: Chen, ZJ Saffitz, JE Latour, MA Schonfeld, G
Citation: Zj. Chen et al., Truncated apo B-70.5-containing lipoproteins bind to megalin but not the LDL receptor, J CLIN INV, 103(10), 1999, pp. 1419-1430
Metabolic modes of action of the statins in the hyperlipoproteinemias
Authors: Aguilar-Salinas, CA Barrett, H Schonfeld, G
Citation: Ca. Aguilar-salinas et al., Metabolic modes of action of the statins in the hyperlipoproteinemias, ATHEROSCLER, 141(2), 1998, pp. 203-207
Risultati: 1-12 |